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Metabolic regulation and immune responses are tightly 
coupled in numerous contexts.  Chronic and acute 
infections can drive metabolic disruption and lead to 
wasting of fatty and lean tissues, a phenomenon 
apparent in many human infections.  Furthermore, 
several metabolic syndromes, particularly obesity and 
diabetes, have an inflammatory component which is 
thought to be a driving force behind the pathology 
associated with these increasingly common diseases [1].  
In aging human populations metabolic dysfunction, 
particularly insulin resistance, and inflammatory 
disorders become increasingly common; however, the 
etiology of these age-related diseases remains unclear 
[2,3].  Identifying the molecular mechanisms that 
underlie metabolic-immune integration is therefore of 
critical importance to our understanding of metabolic 
syndromes, infection-induced pathology and aging.  
In Drosophila, the metabolic and immune consequences 
of aging are tightly correlated, as individuals that show 
increased antimicrobial gene expression also show 
systemic metabolic dysfunction [4].  The metabolic and 
immune phenotypes of individuals undergoing normal 
aging therefore begin to mimic those of animals 
experiencing infection-induced metabolic patho-
physiology. This occurs in the apparent absence of 
infection, and its proximate cause remains unknown.  In 
recent work, we have identified the transcription factor 
MEF2 as a critical transcriptional switch between 
metabolism and immunity [5]. In Drosophila, as in 
vertebrates, chronic or acute infection results in 
metabolic disruption.  In the adult fat body, a structure 
analogous to the vertebrate liver and adipose tissue, 
MEF2 exists in two states with distinct physiological 
functions.  Under normal conditions MEF2 
phosphorylated at T20 promotes the expression of key 
enzymes involved in anabolic metabolism.  However, in 
infected animals T20 phosphorylation is lost and MEF2 
associates with the TATA-binding protein, and drives 
normal expression of multiple antimicrobial peptides.  
MEF2 therefore acts as a switch between distinct 
transcriptional states.   
The integration of anabolic signaling and immune 
activation in this manner may represent an efficient 
program allowing an animal to alter energy usage in the 
face of challenge.  Alternatively, it may arise from 
mechanistic   constraints   resulting   from  the  need  for  
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MEF2 to serve different transcriptional functions under 
different conditions.  In either case, prolonged immune 
activation forces the animal into metabolic 
pathophysiology.  In the absence of infection, when 
chronic immune activation is unnecessary and 
detrimental to the animal, MEF2 is an ideal target for 
intervention. 
In the context of animal aging the identification of a 
single protein which when appropriately controlled 
switches the organism toward anabolic metabolism and 
away from immune activation is of particular interest.  
It is easy to speculate that modulation of the 
phosphorylation status of MEF2 in adult Drosophila 
may ameliorate the affects of aging on two major 
physiological systems, with profound consequences for 
the aging organism. 
Identifying the signaling mechanisms that regulate T20 
phosphorylation of MEF2 will be a key step toward 
elucidating upstream inputs that modulate immune-
metabolic integration via MEF2.  Pursuing this question 
will reveal the events leading to immune and metabolic 
dysfunction, be it in the context of infection, metabolic 
syndromes, or normal aging.  Such insights from the 
Drosophila model may be particularly helpful in 
narrowing the field of candidate pathways as this work 
moves into mammalian model systems.  Immune and 
metabolic signaling pathways are highly conserved 
throughout species; it is therefore sensible to suggest 
that the molecular mechanisms underlying the 
integration of these signals may also be conserved 
across organisms.  In mammals, Mef2 family proteins 
have roles in hematopoiesis, and in B cell and T cell 
function. In addition, Mef2 family proteins are critical 
regulators of muscle metabolism [6,7]. However, the 
potential roles of these proteins as direct activators of 
innate immune responses and regulators of adipose 
metabolism remains to be explored in mammalian 
models.  Nevertheless, identification of the Drosophila 
MEF2 immune-metabolic switch represents a 
significant advance in our understanding of the 
integrated physiology of the organism.   
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